Rockwell Medical Technologies (RMTI) Misses Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Rockwell Medical (RMTI) Signs Triferic Supply Contract with Top Provider, Oppenheimer Notes
November 10, 2015 7:42 AM ESTOppenheimer analyst Ling Wang reiterated an Outperform rating and $26 price target on Rockwell Medical Technologies (NASDAQ: RMTI) following the company Q3 updated. The analyst notes the company singed a signed a supply contract with one of the top four dialysis providers for Triferic, although... More
Rockwell Medical Technologies (RIMT) Triferic Sales Not Material Enough To Even Disclose, Brean Capital Notes
November 10, 2015 6:29 AM ESTBrean Capital analyst Jonathan Aschoff reiterated a Sell rating and $4 price target on Rockwell Medical Technologies (NASDAQ: RMTI) noting Triferic sales were not material enough to even disclose.
Aschoff commented, "Rockwell launched Triferic in the US in September but has not yet generated sales material enough to report separately as Triferic revenue. Rockwell admitted the sales are minimal, and prices are currently being negotiated with individual dialysis providers. We expect... More
